Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer VP James Taylor joins INC Research

He was previously VP global clinical trial management at the US pharma firm

INC Research, James TaylorINC Research has appointed Pfizer's former head of clinical trials James Taylor as its new VP, clinical development.

Taylor, who was VP, global clinical trial management at Pfizer, joins the clinical research organisation (CRO) immediately, and will act as the primary liaison between INC Research and its biopharma customers.

It is the second major personnel change during 2013 for INC Research following the appointment of former chief operating officer Jamie Macdonald to CEO in January.

Macdonald commented on the decision to hire Taylor: "Jim is an accomplished leader with global experience across all phases of complex enterprise operations involving the execution of clinical trials."

He added: "Having worked in large pharma for many years, he brings a strong customer perspective, which allows him to anticipate our customers' needs and communicate their requirements more effectively.”

Taylor spent almost a decade at Pfizer, initially serving as VP, worldwide head contracts and outsourcing before assuming his role in clinical trial management.

Prior to joining Pfizer, Taylor served at Sanofi as senior director outsourcing management and he has also held positions at Baxter Healthcare and Omnicare Clincial Research.

12th March 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics